Skip to main content

Cancer Chemotherapy and Pharmacology

Ausgabe 1/2019

Inhalt (23 Artikel)

Review Article

Awakening the “guardian of genome”: reactivation of mutant p53

Akshay Binayke, Sarthak Mishra, Prabhat Suman, Suman Das, Harish Chander

Review Article

Autophagy and its potent modulators from phytochemicals in cancer treatment

Chao-Yue Sun, Qian-Yu Zhang, Guang-Juan Zheng, Bing Feng

Review Article

Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters

Laure Deyme, Dominique Barbolosi, Florence Gattacceca

Original Article

Clinical and in vitro studies of the correlation between MGMT and the effect of streptozocin in pancreatic NET

Susumu Hijioka, Keiichiro Sakuma, Masahiro Aoki, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Kazuo Hara, Yasushi Yatabe

Original Article

Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy

Jacob Nersting, Stine Nygaard Nielsen, Kathrine Grell, Maria Paerregaard, Jonas Abrahamsson, Bendik Lund, Olafur Gisli Jonsson, Kaie Pruunsild, Goda Vaitkeviciene, Jukka Kanerva, Kjeld Schmiegelow

Original Article

Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients

Brittney R. Starling, Parag Kumar, Andrew T. Lucas, David Barrow, Laura Farnan, Laura Hendrix, Hugh Giovinazzo, Gina Song, Paola Gehrig, Jeannette T. Bensen, William C. Zamboni

Original Article

Plasma and brain pharmacokinetics of letrozole and drug interaction studies with temozolomide in NOD-scid gamma mice and sprague dawley rats

Priyanka Arora, Courtney Huff Adams, Gary Gudelsky, Biplab DasGupta, Pankaj B. Desai

Original Article

Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers

Nathalie Rioux, Amy Kim, Darrell Nix, Todd Bowser, Markus Warmuth, Peter G. Smith, Joanne Schindler

Original Article

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

Kristina Lindemann, Philip J. Beale, Emma Rossi, Jeff C. Goh, Michelle M. Vaughan, Meaghan E. Tenney, Julie K. Martyn, Dirkje Sommeijer, Jose L. Iglesias, Gabriel Kremmidiotis, Jeremy Simpson, Elizabeth Doolin, Tina C. Lavranos, Annabell Leske, Anneso S. Veillard, David Espinoza, Martin R. Stockler, Danny Rischin

Original Article

Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms

Akimitsu Maeda, Kei Irie, Hitoshi Ando, Ayako Hasegawa, Hiroya Taniguchi, Shigenori Kadowaki, Kei Muro, Masahiro Tajika, Masahiro Aoki, Kazuhide Inaguma, Masaki Kajita, Akio Fujimura, Shoji Fukushima

Original Article

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Osman Köstek, Muhammet Bekir Hacıoğlu, Abdullah Sakin, Tarık Demir, Murat Sarı, Ozlem Ozkul, Murat Araz, Aysun Fatma Doğan, Nazım Can Demircan, Sernaz Uzunoğlu, İrfan Çiçin, Bülent Erdoğan

Open Access Original Article

Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer

Hironori Fujii, Yunami Yamada, Daichi Watanabe, Nobuhisa Matsuhashi, Takao Takahashi, Kazuhiro Yoshida, Akio Suzuki

Original Article

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Ece Esin, B. Oksuzoglu, A. Bilici, I. Cicin, O. Kostek, M. A. Kaplan, S. Aksoy, B. Y. Aktas, O. Ozdemir, A. Alacacioglu, D. Cabuk, A. T. Sumbul, A. Sakin, S. Paydas, E. Yetisir, O. Er, T. Korkmaz, N. Yildirim, T. Sakalar, H. Demir, M. Artac, M. Karaagac, H. Harputluoglu, E. Bilen, E. Erdur, S. Degirmencioglu, A. Aliyev, T. Cil, P. Olgun, G. Basaran, O. Gumusay, A. Demir, E. Tanrikulu, P. F. Yumuk, Inanc Imamoglu, B. Oyan, B. Cetin, V. Haksoyler, N. Karadurmus, I. Erturk, T. Evrensel, H. Yilmaz, I. Beypinar, M. Kocer, K. N. Pilanci, M. Seker, Y. Urun, N. Yildirim, T. Eren, U. Demirci, B. Oksuzoglu, A. Bilici, O. Kostek, I. Cicin, M. A. Kaplan, B. Y. Aktas, S. Aksoy, O. Ozdemir, A. Alacacioglu, D. Cabuk, A. T. Sumbul, A. Sakin, E. Yetisir, S. Paydas, O. Er, T. Korkmaz, N. Yildirim, T. Sakalar, H. Demir, M. Karaagac, M. Artac, H. Harputluoglu, E. Bilen, S. Degirmencioglu, A. Aliyev, P. Olgun, T. Cil, G. Basaran, O. Gumusay, A. Demir, E. Tanrikulu, P. F. Yumuk, Inanc Imamoglu, B. Uluc Oyan, B. Cetin, V. Haksoyler, N. Karadurmus, I. Erturk, H. Yilmaz, T. Evrensel, Beypinar, Kocer, K. N. Pilanci, M. Seker, Y. Urun, N. Yildirim, T. Eren, U. Demirci

Original Article

Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial

Koji Murono, Hiroshi Nagata, Kazuhiro Ishimaru, Shigenobu Emoto, Manabu Kaneko, Masaya Hiyoshi, Kazuhito Sasaki, Kensuke Otani, Yasutaka Shuno, Takeshi Nishikawa, Toshiaki Tanaka, Keisuke Hata, Kazushige Kawai, Hiroaki Nozawa, Kei Muro, Soichiro Ishihara

Original Article

Nonclinical pharmacokinetics and in vitro metabolism of H3B-6545, a novel selective ERα covalent antagonist (SERCA)

Nathalie Rioux, Sherri Smith, Manav Korpal, Morgan O’Shea, Sudeep Prajapati, Guo Zhu Zheng, Markus Warmuth, Peter G. Smith

Original Article

A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer

Yasushi Sato, Tamotsu Sagawa, Hiroyuki Ohnuma, Masahiro Hirakawa, Yasuo Takahashi, Kyoko Hamaguchi, Koshi Fujikawa, Takayuki Nobuoka, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Ichiro Takemasa, Tetsuji Takayama

Open Access Original Article

Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics

I. Kümler, P. Grundtvig Sørensen, J. Palshof, E. Høgdall, W. Skovrider-Ruminski, S. Theile, A. Fullerton, P. G. Nielsen, B. Vittrup Jensen, D. L. Nielsen

Original Article

Steroidal dimer by001 inhibits proliferation and migration of esophageal cancer cells via multiple mechanisms

Sai-Qi Wang, Kai-Rui Zhou, Xiao-Li Shi, Hui-Fang Lv, Liang-Yu Bie, Wei-Jie Zhao, Xiao-Bing Chen

Open Access Original Article

Exposure–response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma

Robin L. Jones, Gary Mo, John R. Baldwin, Patrick M. Peterson, Robert L. Ilaria Jr., Ilaria Conti, Damien M. Cronier, William D. Tap

Open Access Original Article

Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study

Kazuo Sato, Yasuharu Toyoshima, Shiho Moriyama, Yutaka Endo, Tetsuhide Ito, Emiko Ohki

Open Access Short Communication

Lack of UGT polymorphism association with idasanutlin pharmacokinetics in solid tumor patients

W. Venus So, Tai-Hsien Ou Yang, Xing Yang, Jianguo Zhi

Correction

Correction to: Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice

Soumaya Labidi, Nesrine Mejri, Houda El Benna, Mehdi Afrit, Sarra Lakhdher, Hamouda Boussen

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.